Skip to main content
. Author manuscript; available in PMC: 2018 Apr 12.
Published in final edited form as: Am J Obstet Gynecol. 2017 May 15;217(3):369.e1–369.e9. doi: 10.1016/j.ajog.2017.05.019

TABLE 3.

Plasma concentrations of 17-alpha hydroxyprogesterone caproate according to genotype of cytochrome P450 single nucleotide polymorphisms

CYP SNP Genotype N Genotypicfrequencies 17 OHP-C ng/mL median (25the75th percentile) Estimatea SE P value
CYP3A4*22
(rs35599367)
GG 243 0.931   9.8 (8e12.4) 0.0339 0.0823 .68
GA   17 0.065 10.2 (7.1e16.5)
AA     1 0.004 10.9 (10.9e10.9)
CYP3A4*1G
(rs2242480)
CC 128 0.559   9.9 (8.2e12.3) 0.0321 0.0416 .44
CT   64 0.279 10.0 (7.2e12.5)
TT   37 0.162 10.0 (8.2e13.5)
CYP3A4*1B
(rs2740574)
TT 184 0.689   9.9 (8.4e12.4) 0.0832 0.0476 .08
CT   58 0.217 11.0 (8.3e13.6)
CC   25 0.094   9.8 (7.9e12.1)
CYP3A5*3
(rs776746)
CC 154 0.592   9.9 (8.3e12.4) 0.0318 0.0414 .44
CT   73 0.281 10.0 (7.2e12.1)
TT   33 0.127   9.9 (8.4e13.3)

SNP, single nucleotide polymorphism; 17 OHP-C, 17-alpha hydroxyprogesterone caproate.

a

Beta estimate, SE, and P value from test of general linear model of genotype in additive model predicting log 17OHP-C; analysis adjusted for prepregnancy body mass index, race, and treatment group.

Bustos et al. Association of CYP3A and PR SNPs and 17 OHP-C. Am J Obstet Gynecol 2017.